| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.38 ▲ +1.59% | Yesterday | $6.24 ▼ -0.67% | Tomorrow's Kalaris Therapeutics Inc. Common Stock (KLRS) setup is anchored to $6.28 and targets $6.38 (+1.59%). The near-term read is upside; watch $6.47 / $6.09 because daily realized volatility is about 8.00%. |
Tomorrow's Kalaris Therapeutics Inc. Common Stock (KLRS) setup is anchored to $6.28 and targets $6.38 (+1.59%). The near-term read is upside; watch $6.47 / $6.09 because daily realized volatility is about 8.00%. | ||||
| Week | $6.59 ▲ +4.95% | Last Week | $6.15 ▼ -2.08% | The 7-day Kalaris Therapeutics Inc. Common Stock model moves from $6.15 to $6.59 (+4.95%). It gives upside momentum context for this stock, so breaks around $6.47 / $6.09 matter more than a single tick. |
The 7-day Kalaris Therapeutics Inc. Common Stock model moves from $6.15 to $6.59 (+4.95%). It gives upside momentum context for this stock, so breaks around $6.47 / $6.09 matter more than a single tick. | ||||
| Month | $6.94 ▲ +10.54% | Last Month | $6.00 ▼ -4.43% | The 1-month Kalaris Therapeutics Inc. Common Stock target is $6.94 (+10.54%), compared with the live reference near $6.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Kalaris Therapeutics Inc. Common Stock target is $6.94 (+10.54%), compared with the live reference near $6.28. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $7.47 ▲ +18.93% | Last Year | $5.78 ▼ -7.95% | The 1-year Kalaris Therapeutics Inc. Common Stock scenario points to $7.47 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Kalaris Therapeutics Inc. Common Stock scenario points to $7.47 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $8.70 ▲ +38.57% | 5 Years Ago | $5.26 ▼ -16.20% | The 5-year Kalaris Therapeutics Inc. Common Stock view is $8.70 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Kalaris Therapeutics Inc. Common Stock view is $8.70 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $6.28 | Mid |
| Daily Change | -4.85% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $6.28 | Daily Change | -4.85% |
| Market Cap | $143.99M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.